The identification of barriers preventing the successful implementation of a surgical prophylaxis protocol

被引:4
作者
Burnett, KM
Scott, MG
Kearney, PM
Humphreys, WG
McMillen, RM
机构
[1] Antrim Area Hosp, Antrim Hosp Acad Pharm Practice Unit, Belfast BT41 2RL, Antrim, North Ireland
[2] Antrim Area Hosp, Dept Microbiol, Belfast, Antrim, North Ireland
[3] Antrim Area Hosp, Surg Directorate, Belfast, Antrim, North Ireland
[4] Antrim Area Hosp, Woman & Child Hlth Directorate, Belfast, Antrim, North Ireland
来源
PHARMACY WORLD & SCIENCE | 2002年 / 24卷 / 05期
关键词
compliance; implementation; prophylaxis; protocols; surgery;
D O I
10.1023/A:1020565000571
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: The aim of this study was to introduce a protocol for the use of antimicrobials in surgical prophylaxis for the described procedures in Antrim Area Hospital. Method: Historical data of antimicrobial use were obtained from retrospective analysis of patients' charts, for those patients identified as having one of the following 'clean'/contaminated' surgical procedures over the previous six months; cholecystectomy or abdominal hysterectomy. These data were analysed, and a protocol was introduced providing guidelines for the choice of antimicrobial agent, its administration time, route, dose, duration and frequency of treatment. Main outcome measure: The main outcome measure was the success of the uptake of the protocol following its implementation. Results: There was a total of 285 patients identified, 105 prior to and 180 post implementation. Overall, 68% of patients received some form of prophylaxis in the first cycle, and 72% in the second. Conclusion: Although the introduction of the protocol led to slight improvements in compliance with standard prescribing procedures, with an increase in single-dose prophylaxis, and a reduction in prolonged prophylactic treatment, the improvements did not reach expectations. This paper attempts to identify the possible barriers to protocol implementation.
引用
收藏
页码:182 / 187
页数:6
相关论文
共 34 条
  • [1] ABRAMOWICZ M, 1997, MED LETT, V39, P97
  • [2] [Anonymous], 1997, HOSP ACQUIRED INFECT
  • [3] *ASHP COMM THER, 1999, AM J HEALTH-SYST PH, V56, P1840
  • [4] BAILEY H, 1992, PJ, V249, pR33
  • [5] PROPHYLACTIC ANTIBIOTICS IN GASTRODUODENAL SURGERY
    BALLAY, JL
    MALLEDANT, Y
    BLERY, C
    QUEMENER, C
    [J]. ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 1994, 13 (05): : S135 - S137
  • [6] BARRIERE SL, 1992, AM J HOSP PHARM, V49, P1493
  • [7] Burke J F, 1973, Am Surg, V39, P6
  • [8] Dellinger E P, 1996, Eur J Surg Suppl, P29
  • [9] DELLINGER EP, 1994, INFECT CONT HOSP EP, V15, P182
  • [10] DICKINSON GM, 1995, INFECT DIS CLIN N AM, V9, P783